Skip to main content
logo
TG Therapeutics, Inc. (FRA:NKB2)
Germany flag Germany · Delayed Price · Currency is EUR
26.61
-0.13 (-0.50%)
At close: Jan 23, 2026

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Novel Treatments for B-cell Diseases
329.00M
Novel Treatments for B-cell Diseases Growth
40.80%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
United States
329.00M
United States Growth
40.80%